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ABSTRACT
Studies from other parts of the world showed high rates of substance use among people 
with severe mental illness. A cross-sectional survey of 385 outpatients attending the 
Mental Health Care Centre at the Windhoek Central Hospital was conducted. It aimed 
to determine the prevalence of substances use and the type of substance abused by 
patients. About thirty-two percent of participants used alcohol, 21% used nicotine and 
9% used illicit drugs. The use of substances was associated with male gender and young 
age. There were significant associations between alcohol use and psychiatric conditions, 
but not between psychiatric conditions and the use of nicotine or illicit drugs. Comorbid 
substance use and mental illness point to the need for a comprehensive approach that 
identifies, evaluates, and simultaneously treats both disorders.
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INTRODUCTION
There is a reciprocal connection be-
tween mental illness and substance 
abuse. People who abuse alcohol or 
other drugs tend to develop mental ill-
nesses, and people with certain mental 
conditions tend to develop substance 
abuse problems. The most common issue 
connecting mental illness and substance 
abuse is the intention of patients to medi-
cate the mental health symptoms that 
they find disruptive or uncomfortable by 
using alcohol and drugs. (Mental Health 
Care, 2012).
Alcohol can be used as a form of cop-
ing for severe mental illness. It can tem-
porarily alleviate feelings of anxiety and 
depression, and people often use it in an 
attempt to cheer themselves up or some-
times help with sleep (Netdoctor, 2015). 
Alcohol consumption can make existing 
mental health problems worse. Evidence 
shows that alcohol consumption can be a 
contributing factor to some mental health 
problems, such as depression (Peltzer, 
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2015; Rotheram-Borus, 2015). In addi-
tion to the direct pharmacological effects 
of alcohol on brain function, psychosocial 
stressors that commonly occur in patients 
who abuse alcohol, such as legal, finan-
cial, or interpersonal problems may indi-
rectly contribute to ongoing alcohol-relat-
ed symptoms, such as sadness, despair, 
and anxiety (Anthenelli, 1997; Anthenelli 
et al., 1993).
The prevalence of smoking in people 
with a severe mental illness is about three 
times the general population (Royal College 
of Physicians, 2013). Williams, Steinberg, 
Griffiths and Cooperman, (2013) reported 
that people with mental illness have higher 
smoking rates, higher levels of nicotine de-
pendence, lower cessation rates and a dis-
proportionate health and financial burden 
from smoking compared with the general 
population. People with mental illness who 
smoke are far more likely to die as a con-
sequence of smoking than from their psy-
chiatric condition (Williams, et al., 2013). 
Smoking is also a predictor of suicide even 
after controlling for mental illness, and the 
risk falls after cessation. (Yaworski, Robin-
son, Sareen & Bolton, 2011). 
The prevalence of cannabis use is twice 
as high among people with mental disor-
ders compared to the general population 
(Green, Young & Kavanagh, 2005). Studies 
show that the use of cannabis can trigger 
psychoses and lead to persistence of psy-
chotic symptoms (Kuepper, et al., 2013; 
Semple, et al., 2005).
Alcohol and drug misuse and abuse are 
among the most significant health con-
cerns that face Namibia today. Consump-
tion of alcohol is widespread in Namibia. 
Data from the World Health Organization 
Noncommunicable Disease (WHO NCDs) 
Country Profiles indicate that Namibia has 
one of the highest average total per capita 
alcohol consumption of 10.8 L for both 
men and women in the region (World 
Health Organization, 2018). Adverse ef-
fects of alcohol consumption found in the 
Namibian context include higher rates of 
violence, arguments, crime, health and 
financial problems (Ministry of Health 
and Social Services, 2013). The 2018 
NCDs country profiles indicate that Na-
mibia has a high prevalence of tobacco 
smoking (20% average for both men and 
women; 30% for men and 9% for women). 
There is limited data on the prevalence 
of substance use among the mentally ill 
in Namibia. Therefore, the objective of 
the study was to identify the prevalence 
of substance use among the patients at-
tending the Mental Health Care Centre 
(MHCC), explore the association of mental 
conditions and substance use, and factors 
associated with the use of substances.
METHOD
Study Design, Setting, and Participants
This cross-sectional study was conduct-
ed between May and December 2017 at 
the outpatient of MHCC, Windhoek Cen-
tral Hospital. The MHCC is a referral and 
teaching health facility. The study popu-
lation was service users with mental ill-
ness attending outpatient service of the 
MHCC. All patients attending the MHCC 
are registered at the outpatient of that 
facility. Inclusion criteria were adult pa-
tients attending the outpatient of MHCC, 
aged 18 years and above, and those who 
could independently provide informed 
consent to participate in the study.
Material
The Alcohol Use Disorders Identifica-
tion Test (AUDIT) that was designed by 
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WHO (World Health Organization, 2001) 
to screen for hazardous and harmful 
drinking, was administered to all par-
ticipants to assess alcohol consumption, 
drinking behaviours, and alcohol-related 
problems. The WHO guidelines for the 
AUDIT (Babor, Higgins-Biddle, Saun-
ders,& Monteiro, 2001) specify four 
“zones” (shown in Table 1) of scores 
that indicate increasing levels of alcohol-
related risk. 
The Fagerstrom Test for Nicotine De-
pendence (FTND) was used to evaluate 
the quantity of cigarette consumption, 
the compulsion to use, and dependence 
(Heatherton, Kozlowski, Frecker & Fager-
strom, 1991). The dependence scores are 
very low 0-2; low 3-4; moderate 5; very 
high 8-10. The higher the total Fagerström 
score, the more intense is the patient’s 
physical dependence on nicotine. 
 Illicit drugs use was determined dur-
ing an interview on health behaviours. 
Patients were asked whether they used 
cannabis, mandrax, cocaine, heroin, and 
other illegal drugs during the last three 
months, and how much they used per 
week.
Procedure
A systematic random sampling method 
was used. Every fourth patient was given 
a number to take part in the study. In cas-
es where the fourth patient was a child or 
had no capacity to give consent, the sub-
sequent patient was assessed.
Medical officers at MHCC referred pa-
tients to participate in the study after the 
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Table 1. Zones of alcohol risk levels
Score Zone Risk level
0-7 Low risk Zone I Abstinence/lower risk drinking
8-15 Medium risk Zone II Hazardous use
16-19 High risk Zone III Harmful use
20- 40 Zone IV Possible dependence
Adapted from Babor et al., 2001
Figure 1. Number of study participants
28
routine assessment and management. 
Patients were reviewed for inclusion 
criteria; those who did not meet the re-
quirements were thanked and excluded 
from the study. For those who were eligi-
ble and willing to participate in the study, 
explanations about the study were made, 
and informed consent forms were signed. 
An explanation was provided to all partici-
pants that their participation was entirely 
voluntary. Participants were advised that 
there would be no material gain from the 
study, and they may withdraw from the 
study at any time in the course of the in-
terview. Participants were further assured 
that refusal to participate would not in 
any way affect their health services/ben-
efits to which they are entitled.
Ethics
Approval to carry out the study was ob-
tained from the Ethics and Research Com-
mittee from the Ministry of Health and So-
cial Services, Windhoek, Namibia. Author-
isation of patients’ participation was also 
sought from the institution’s head. Once 
the study procedures had been explained, 
all participants provided their written con-
sent to participate. The patients who did 
not consent to participate were excluded. 
Moreover, to ensure patient confidential-
ity, serial numbers were assigned to pa-
tients to replace their names.
RESULTS
Data Analysis and Processing
The data were analysed using the IBM 
SPSS Statistics version 23. The dataset 
was coded before data entry and then 
checked for errors and outliers. Descrip-
tive summary statistics in the form of 
measures of centrality and dispersion, 
frequency distributions, and charts were 
used to establish patterns of alcohol and 
drug use in patients with mental disor-
ders attending MHCC. 
Cross tabulations and chi-square 
tests of association were conducted to 
establish whether significant associations 
existed between the following variable 
pairs at 5% level: Demographic data and 
psychiatric conditions versus smoking/
alcohol/illicit drugs. 
Characteristics of the Study Population
Table 2 shows the clinical and demo-
graphic characteristics of the participants 
in association with the use of substanc-
es. Of the 385 participants, 52.2% were 
males, and 47.8% were females. The 
mean age at enrolment was 37.14 years 
and a standard deviation of 10.44 years. 
Forty-eight percent of the participants 
were middle-aged, 67.8% had secondary 
education, and 79% were single. About 
half of the participants were unemployed, 
and 60% were of a low socio-economic 
status.
Out of the total participants, 122 
(31.7%) used alcohol, 80 (20.8% smoked 
tobacco, and 35 (9.1%) used illicit drugs. 
Alcohol use was common among males 
42.7%, youth 37.2%, and those with de-
pressive disorders 43.9%. Of those who 
used alcohol, 75.2% were in zone I, 13.2% 
were in zone II, 3.4% were in zone III, and 
7.5% were in zone IV of alcohol risk levels. 
About 24% of the participants used alco-
hol harmfully/hazardously or were pos-
sibly dependent on alcohol. There was a 
significant association between the pa-
tient’s psychiatric condition and alcohol 
use (χ2=20.450, p=0.002), but there was 
no significant association between the 
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Table 2. Association between demographic and clinic Characteristics of participants 
and use of substances
Demographic and clinical Characteristics Entire Sample
Substance use among participants
Alcohol Tobacco Illicit drugs
Sex
Female 184(47.8%) 36 (19.6%) 18(9.8%) 2 (1.1%)
Male 201(52.2%) 86(42.7%) 62 (30.8%) 33 (16.4%)
P-value <0.001 <0001 <0.001
Age group in years
Youth (18-35) 180(46.8%) 67(37.2%) 35(19.4%) 23(12.8%)
Middle age (36-55) 185(48.0%) 53(28.6%) 38 (20.5%) 12(6.5%)
Older people (56 and above) 20(5.2%) 2(10.0%) 7 (35.0%) 0(0.0%)
P-value = 0.012 =0.266 =0.038
Marital Status
Single 304(79%) 100 (32.9%) 84(27.6%) 33 (10.5%)
Married 58(15.1%) 16(27.6%) 10 (17.2%) 2 (3.4%)
Separated 13(3.4%) 6 (46.1%) 4(30.8%) 0(0.0%)
Widowed 10(2.6%) 0 (0.0%) 2(20.0%) 0(0.0%)
P-value =0.094 =0.739 <0.125
Education
None 7(1.8%) 5(71.4%) 3 (42.8%) 3(42.8%)
Primary 58(15.1%) 15 (25.9%) 12(20.7%) 0(0.0%)
Secondary 261(67.8%) 80 (30.6%) 57 (21.8%) 29 (11.1%)
Tertiary 56(14.5%) 22(39.3%) 11(19.6%) 6(10.7%)
P-value =0.415 =0.574 =0.047
Occupation
Student 28(7.3%) 9 (32.1%) 1(3.6%) 2(7.1%)
Self-employed 25(6.5%) 9 (36.0%) 8 (32.0%) 3(12.0%)
Employed 117(30.4%) 42 (35.9%) 17 (14.5%) 9 (7.7%)
Unemployed 198(51.4%) 61(30.8%) 50 (26.5%) 21(10.6%)
Other 16(4.2%) 1(6.2%) 4(25.0%) 0 (0.0%)
P-value =0.070 =0.011 =0.631
Socio-economic status
Low (Never employed) 230(59.7%) 69 (30.0%) 55 (23.9%) 24 (10.4%)
Medium (other employment) 127(33.0%) 43 (33.8%) 21(16.5%) 9 (7.8%)
High(White collar job) 22(5.7%) 10 (45.4%) 4(18.1%) 2(9.0%)
P-value <0.641 =0.186 <0.584
Psychiatric conditions
Schizophrenia Spectrum and Other 
Psychotic Disorders
210(54.5%) 68 (32.4%) 45 (21.4%) 24 (11.4%)
Bipolar and Related Disorders 68(17.7%) 12 (17.6%) 13(19.1%) 2(2.9%
Depressive Disorder 86(22.3%) 36 (43.9%) 18 (21.9%) 7 (8.5%)
Others 21(5.5%) 4(19.0%) 2(9.5%) 2(9.5%
P-value =0.002 =0.073 =0.237
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The percentage distribution of patients 
according to the FTND was Very low (7.8 
%), Low (9.1%); Moderate (1.8%); High 
(1.3%); Very high (0.8%). There was no 
significant association between the par-
ticipants’ psychiatric condition and to-
bacco use (χ2 = 11536, P-value = 0.073). 
Among those who used illicit drugs, 30 
(85.7%) used cannabis, while 5 (14.3%) 
used cocaine. The following substance-
induced conditions were identified: Al-
cohol-Induced Psychotic Disorder (6.5%), 
Alcohol-Induced Depressive Disorder 
(1.8%), and Cannabis Induced Psychotic 
Disorder (1.8%).
Factors Associated with Substance Use
The gender of the patient was sig-
nificantly associated with smoking 
(χ2=25.151, p<0.001), alcohol drinking 
(χ2=21.190, p<0.001) and use of illicit 
drugs (χ2=25.813, p<0.001). Even though 
there was no significant association be-
tween the age of the patient and smok-
ing, there was a significant association 
between the age of the patient and 
their alcohol or illicit drug use (χ2=8.785, 
p=0.012, χ2=6.516, p=0.038 respec-
tively). The marital and socio-economic 
status of the patient did not significantly 
influence smoking, alcohol or illicit drug 
use. The level of education of the patient 
only influenced the use of illicit drugs 
(χ2=7.968, p=0.047). There was a signifi-
cant association between the occupation 
of the patient and their smoking status 
(χ2=13.139, p=0.011). Alcohol use was 
significantly associated with tobacco 
use (χ2 =19.693, p<0.001). The highest 
percentage of alcohol users was among 
those who use tobacco. However, there 
was no significant association between 
alcohol use and cannabis use (χ2=4.180, 
p=0.382). 
Regression Analysis of the Effect of 
Demographics and Type of Psychiatric 
Condition on Substance Use
Table 3 shows the regression results 
of the effect of demographics and type 
of psychiatric condition on alcohol use. 
Female patients (OR=0.246, 95% CI 
0.142-0.424, p<0.001) were less likely 
to drink alcohol compared to their male 
counterparts. Younger patients (18-35 
years) (OR=3.240, 95% CI 1.104-9.504, 
p=0.032) were more likely to drink al-
cohol compared to older people (aged 
55 years and above). The level of educa-
tion, occupation or their marital status 
did not significantly influence alcohol 
use.
Regression results of the effect of de-
mographics and type of psychiatric condi-
tion on tobacco use are shown in Table 4. 
Female patients (OR=0.159, 95% CI 0.082-
0.308, p<0.001) were less likely to use to-
bacco compared to their male counter-
parts. The youth (18-35) (OR=0.217, 95% 
CI 0.076-0.618, p=0.004) and middle-aged 
patients (OR=0.336, 95% CI 0.129-0.879, 
p=.0.026) were less likely to use tobacco 
compared to older people (aged 55 and 
above). The type of psychiatric condition, 
socio-economic status, level of education, 
occupation or the marital status of the pa-
tient, did not significantly affect tobacco 
use.
Regression results of the effect of de-
mographics and type of psychiatric con-
dition on illicit drug showed that female 
patients (OR=0.036, 95% CI 0.008-0.168, 
p<0.001) were less likely to use illicit 
drugs compared to their male counter-
parts. Illicit drug use was not significantly 
affected by socio-economic status, age 
group, psychiatric condition, level of edu-





The main aim of the study was to 
identify the prevalence of substance use 
among the service users at MHCC of the 
Windhoek Central Hospital. The findings 
show that 31.7% of the participants use 
alcohol, 21% use nicotine and 9% use 
illicit drugs. Substance use was higher 
among people with mental illness com-
pared to the general population where 
27.7% of Namibians aged 15 years and 
above reported to consume alcohol 
(Ministry of Health and Social Servic-
es, 2013), and 20.0% smoked tobacco, 
(World Health Organization, 2018). The 
use of illicit drugs was about three times 
high compared to the general population, 
where 2.6% used cannabis and 0.4% used 
mandrax (Government of the Republic of 
Namibia 2002). 
The results of this study concur with 
findings of studies from other parts of 
Africa (Okpataku, et al., 2014, Saban, et 
al., 2010) that revealed use of substanc-
es, particularly alcohol and cannabis, 
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Table 3. Logistic regression of the effect of demographics and type of psychiatric 








Female <0.001 0.246 0.142 0.424
Male (Ref) 1.000
Socio-economic Status
Low (Never Employed) 0.867 0.873 0.179 4.256
Medium (Other Employment 0.015 0.285 0.103 0.786
High (White Collar Job) (Ref) 1.000
Age Group
Youth (18-35) 0.032 3.240 1.104 9.504
Middle Aged (36-55) 0.099 2.329 0.853 6.354
Older People (56 and Above) (Ref) 1.000
Education
Primary or No Formal Education 0.665 0.859 0.432 1.707
Secondary and Tertiary (Ref) 1.000
Type of psychiatric condition
Schizophrenia spectrum and other psychotic disorders 0.337 0.633 0.249 1.611
Bipolar and related disorders 0.040 0.330 0.115 0.950
Depressive Disorders 0.272 1.701 0.659 4.391
Others (Ref) 1.000
Occupation
Unemployed, Students and Others 0.142 0.358 0.091  1.412
Employed (Ref) 1.000
Marital Status
Single, Separated or Widowed 0.319 1.425 0.710 2.859
Married (Ref) 1.000
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among persons with severe mental 
illness to be higher than the general 
population. Studies attribute the high 
prevalence of substance use among 
people with mental illness to self-med-
ication (Mental Health Care, 2012). At 
times when a person is suffering from 
a mental health disorder, they are un-
aware that the condition exists. They 
may experience feelings of anger, hope-
lessness, depression, or impulsiveness. 
Because of this, they find themselves at 
times turning to unhealthy behaviours 
such as the use of substances in an 
attempt to numb their psychological 
suffering. 
Although alcohol and drugs may tem-
porarily numb the symptoms that the 
user is experiencing, self-medicating can 
lead to severe problems. This can cause 
those suffering to consume large quanti-
ties of alcohol or drugs and may eventu-
ally develop an addiction. About 17% of 
the participants consumed alcohol either 
hazardously or harmfully, and 7.5% were 
dependent on alcohol. 
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Table 4. Logistic regression of the effect of demographics and type of psychiatric 
condition on tobacco use
Risk factors p-value Odds Ratio




Female <0.001 0.159 0.082 0.308
Male (Ref) 1.000
Socio-economic Status
Low (Never Employed) 0.100 4.637 0.746 28.831
Medium (Other Employment 0.999 0.999 0.285 3.496
High (White Collar Job) (Ref) 1.000
Age Group
Youth (18-35) 0.004 0.217 0.076 0.618
Middle Aged (36-55) 0.026 0.336 0.129 0.879
Older People (56 and Above) (Ref) 1.000
Education
Primary or No Formal Education 0.071 0.470 0.207 1.068
Secondary and Tertiary (Ref) 1.000
Type of psychiatric condition
Schizophrenia spectrum and other psychotic disorders 0.365 0.593 0.192 1.836
Bipolar and related disorders 0.983 1.013 0.306 3.350
Depressive Disorders 0.701 1.250 0.400 3.905
Others (Ref) 1.000
Occupation
Unemployed, Students and Others 0.409 0.535 0.121 2.366
Employed (Ref) 1.000
Marital Status
Single, Separated or Widowed 0.346 1.481 0.654 3.355
Married (Ref) 1.000
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The study by Dickerson et al., 2013, 
found 64% of people with schizophre-
nia to be smokers. In this study, 22% of 
participants with depression and 21.4% of 
participants with schizophrenia smoked. 
Although the findings show that most of 
those who use nicotine were in the very 
low or low level of usage, about 4% were 
in the moderate to high level of usage. 
Smoking has a powerful negative impact 
on population health. In Namibia, smok-
ing is a known risk factor for cardiovascu-
lar disease; it causes lung cancer and oth-
er forms of cancer and contributes to the 
severity of pneumonia, emphysema, and 
chronic bronchitis (Ministry of Health and 
Social Services, 2013). It may also have an 
impact on individuals who are exposed to 
second-hand smoke.
Drugs and alcohol often do little to ad-
dress the underlying mental health symp-
toms and ultimately create an entirely 
new batch of problems for the patient 
while also increasing the severity of the 
initial mental health symptoms. A study 
by Rush et al., 2008 found about 20% of 
people with a mental illness to have a 
co-occurring substance use problem, and 
15% of people with a substance use prob-
lem to have a co-occurring mental illness. 
Among the participants in this study, 
11.7% had a diagnosis of a substance-in-
duced disorder. This supports the fact that 
substance use is a risk factor to develop 
mental illness. The co-occurrence of men-
tal illness and substance use is a manage-
ment problem of both disorders. It had 
been found to be associated with poor 
medication adherence, increased psychi-
atric admission, and poor treatment out-
come (Hunt, Bergen, Bashir. 2002).
Sex is one of the factors that place in-
dividuals at risk of substance use. The 
results obtained concur with findings by 
Pearson, Janz and Ali (2013) that males 
were more likely than females to use sub-
stances. In this study, 42.7% of men use 
alcohol, compared to 19.6% of females, 
and 16.4% of males used illicit drugs, 
while only 1% of females used illicit drugs. 
These differences could be due to the 
conventional norms of male socialisation 
concerning alcohol use and smoking. The 
Namibian demographic and health survey 
also showed that males were twice more 
likely to use alcohol compared to females: 
50% versus 25% (Ministry of Health and 
Social Services, 2013). 
Although socio-economic status (SES) 
is the other factor reported influencing a 
person’s substance use (Charitonidi, et al., 
2016; Patrick et al., 2012), this study did 
not find the influence of socio-economic 
status on substance use. Future studies 
are needed to fully explore the underlying 
mechanisms of the relationship between 
SES and substance use. 
The study has its limitations that should 
be considered in interpreting the findings. 
First, study participants were included 
based on their capacities, and willingness 
to participate, which could contribute to 
a potential reporting bias. Secondly, the 
participants were recruited at one health 
institution only, which could also repre-
sent another potential bias. Although the 
results are not broadly generalisable, the 
study results do have relevance and give 
insight on the use of substances among 
the mentally ill, attending the Windhoek 
Central Hospital.
In conclusion, the use of alcohol, can-
nabis and tobacco was common among 
patients with mental illness. This points 
to the need for an integrated approach 
to the identification, evaluation, and si-
multaneous treatment of both psychiatric 
and substance use disorders. 
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